Skip to main content

Standard Biotools Inc.

LAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001162194

No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding Standard Biotools Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of LAB: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1191121+3
Shares58.6M188.7K56.3M−2.16M (−3.7%)
Value$386.6M$1.24M$220.4M−$164.9M (−42.8%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Standard Biotools Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to LAB in Q4 2021
InstitutionSharesValue% of portfolio
Repertoire Partners LP1,000,000$3.92M3.24%
Verition Fund Management LLC230,523$904.0K0.01%
HighTower Advisors, LLC191,630$751.0K0.00%
Tudor Investment Corp Et Al121,248$475.0K0.01%
Campbell & CO Investment Adviser LLC98,000$384.0K0.13%
Ergoteles LLC54,948$215.0K0.01%
Prescott Group Capital Management, L.L.C.53,236$209.0K0.05%
Manteio Capital LLC26,213$103.0K0.13%
Alpine Global Management, LLC25,333$99.0K0.01%
Gabelli Funds LLC20,618$81.0K0.00%
Cubist Systematic Strategies, LLC17,760$70.0K0.00%
Renaissance Technologies LLC17,500$69.0K0.00%
ProShare Advisors LLC16,646$65.0K0.00%
Commonwealth Equity Services, LLC15,452$60.0K0.00%
Janus Henderson Group PLC14,407$56.0K0.00%
Aigen Investment Management, LP10,382$43.0K0.00%
State of Wyoming3,497$14.0K0.01%
CarsonAllaria Wealth Management, Ltd.2,515$10.0K0.01%
Point72 Hong Kong Ltd693$3.00K0.00%
US Bancorp352$1.00K0.00%
Ensign Peak Advisors, Inc80$00.00%
CWM, LLC40$00.00%

Sold out (19)

Institutions that held Standard Biotools Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Not filed for Q4 2021 yet (1)

Institutions that held Standard Biotools Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LAB in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Alexandria Capital, LLC188,700$1.24M